surmount 1 tirzepatide for the Maintenance of Body Weight Reduction: Rationale, Design, and Baseline Characteristics of SURMOUNT‐MAINTAIN - Horn - 2025 - Obesity SURPASS to SURMOUNT: The Tirzepatide

Never discontinue tirzepatide without medical consultation, as abrupt cessation may affect your glycemic control or weight management progress

Weight loss results in this time will usually be slow, and that's normal

Many experienced users actually prefer syringes because of the dosing flexibility they provide, especially for microdosing protocols that require precise, small-volume adjustments impossible with standard pen increments

The titration schedule determines how quickly you ramp up to your target dose and directly affects both results and side effects

Personalized approaches using genetic testing to predict GLP-1 agonist response may emerge

If the vial was at room temperature for less than 24 hours and stayed below 86 degrees Fahrenheit, it is generally safe to continue using